Literature DB >> 33001279

Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma.

Donald C Moore1, Viera Nelson2, Alaa Muslimani3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33001279     DOI: 10.1007/s00277-020-04285-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  1 in total

1.  Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size.

Authors:  Celine Berthon; Morgane Nudel; Eileen M Boyle; Laure Goursaud; Thomas Boyer; Alice Marceau; Bruno Quesnel
Journal:  Leuk Res Rep       Date:  2020-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.